Skip to content

EPS (Basic) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.17-52.5%
Stryker logo
StrykerSYK
$1.95+14.0%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$1.22+32.6%
Medtronic logo
MedtronicMDT
$0.98+18.1%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$0.05+600%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$0.52+61.5%

Other financials

Income statement

See full
Revenue$19.9M+14.6%
Gross profit$6.1M+5.8%
Operating income$3.1M-15.0%
Net income$3.9M+20.2%
EPS (diluted)$1.20+22.4%

Balance sheet

See full
Cash & equivalents$10.0M+123%
Total debt$16.0M+43.2%
Total equity$45.2M+28.1%
Total assets$75.0M+16.7%

Cash flow

See full
Operating cash flow$1.6M+488%
CapEx$112.0K-37.8%
Free cash flow$1.5M

Valuation

See full
Market cap$195.81M+39.3%
Enterprise value$201.8M+34.4%
P/E16.3×+0.7×
P/S2.6×+0.5×

Profitability

See full
Gross margin27.8%-3.6pp
Operating margin14.5%-3.8pp
Net margin16.1%+1.5pp
FCF margin-3.8%+3.2pp

Returns & leverage

See full
Return on equity29.8%+1.5pp
Debt / equity0.4×0.0×
Current ratio3.7×+0.9×

Where this comes from

Reported directly by Pro-Dex, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: Pro-Dex, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pro-Dex, Inc.'s eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pro-Dex, Inc.'s EPS (basic)?
Pro-Dex, Inc. (PDEX) reported EPS (basic) of $1.23 in Q1 2026.
How has Pro-Dex, Inc.'s EPS (basic) changed year-over-year?
Pro-Dex, Inc.'s EPS (basic) increased by 23.0% year-over-year, from $1.00 to $1.23.
What is the long-term trend for Pro-Dex, Inc.'s EPS (basic)?
Over 3 years (2022 to 2025), Pro-Dex, Inc.'s EPS (basic) has grown at a 29.5% compound annual growth rate (CAGR), from $1.27 to $2.76.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.